OncoAlert and ecancer - ESMO 2021 Day 2
OncoAlert and ecancer - ESMO 2021 Day 2
Erdafitinib (ERDA) or ERDA plus cetrelimab for patients with metastatic or locally advanced urothelial carcinoma (mUC) and FGFRa
ESMO President: What to watch for at ESMO 2021
OncoAlert and ecancer weekly round up for August 23rd - August 29th, 2021
OncoAlert and ecancer weekly round up for August 16th - August 22nd, 2021
Current state of prostate cancer in Antigua and Barbuda
OncoAlert and ecancer weekly round up for August 2 - August 14, 2021
Patterns of recurrence after a radical nephroureterectomy in high-risk upper tract urothelial carcinoma
OncoAlert and ecancer weekly round up for July 19 - July 25, 2021
Part 1: When to test
Part 2: Who to test
Part 3: How to test